Literature DB >> 12359148

Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies.

Simona Capsoni1, Sabina Giannotta, Antonino Cattaneo.   

Abstract

Cerebral deposition of beta-amyloid (Abeta) is an invariant event of Alzheimer's disease (AD). We recently described that the brain of aged transgenic mice expressing anti-nerve growth factor (NGF) antibodies (AD11 mice) show a dramatic neurodegenerative phenotype, reminiscent of AD, which includes neuronal loss, cholinergic deficit, and tau hyperphosphorylation, associated with neurofibrillary pathology. We now report that brains of aged transgenic mice contain large amounts of beta-amyloid plaques and describe their morphology by a variety of approaches. In conclusion, the chronic deprivation of NGF leads to the formation and deposition of Abeta in AD11 mice, suggesting a direct link between NGF signaling and abnormal processing of amyloid precursor protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359148     DOI: 10.1006/mcne.2002.1163

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  30 in total

1.  Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.

Authors:  Neil J Johnson; Leah R Hanson; William H Frey
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 2.  On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.

Authors:  Simona Capsoni; Antonino Cattaneo
Journal:  Cell Mol Neurobiol       Date:  2006-08-31       Impact factor: 5.046

3.  NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons.

Authors:  Carmela Matrone; Maria Teresa Ciotti; Delio Mercanti; Roberta Marolda; Pietro Calissano
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

Review 4.  Neuroprotective strategies in Alzheimer's disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  NeuroRx       Date:  2004-01

Review 5.  The depolarizing action of GABA controls early network activity in the developing hippocampus.

Authors:  Enrico Cherubini; Marilena Griguoli; Victoria Safiulina; Laura Lagostena
Journal:  Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.590

6.  Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment.

Authors:  Rainer Hellweg; Peter Lohmann; Roman Huber; Alexander Kühl; Matthias W Riepe
Journal:  Learn Mem       Date:  2006-01-17       Impact factor: 2.460

Review 7.  Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.

Authors:  Reinhard Schliebs
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

8.  Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration.

Authors:  Simona Capsoni; Cecilia Tiveron; Domenico Vignone; Gianluca Amato; Antonino Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

9.  In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction.

Authors:  Laura Lagostena; Marcelo Rosato-Siri; Mara D'Onofrio; Rossella Brandi; Ivan Arisi; Simona Capsoni; Jessica Franzot; Antonino Cattaneo; Enrico Cherubini
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

Review 10.  The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP.

Authors:  Carol A Colton; Donna M Wilcock; David A Wink; Judianne Davis; William E Van Nostrand; Michael P Vitek
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.